These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 10088018)

  • 41. Contribution of lymphatic transport to the systemic exposure of orally administered moxidectin in conscious lymph duct-cannulated dogs.
    Lespine A; Chanoit G; Bousquet-Melou A; Lallemand E; Bassissi FM; Alvinerie M; Toutain PL
    Eur J Pharm Sci; 2006 Jan; 27(1):37-43. PubMed ID: 16198549
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Factors associated with prognosis for survival and athletic use in foals with septic arthritis: 93 cases (1987-1994).
    Steel CM; Hunt AR; Adams PL; Robertson ID; Chicken C; Yovich JV; Stick JA
    J Am Vet Med Assoc; 1999 Oct; 215(7):973-7. PubMed ID: 10511863
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Enhancement of oral moxidectin bioavailability in rabbits by lipid co-administration.
    Bassissi MF; Lespine A; Alvinerie M
    Parasitol Res; 2004 Oct; 94(3):188-92. PubMed ID: 15338286
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Fell pony immunodeficiency syndrome also occurs in the Netherlands: a review and six cases.
    Butler CM; Westermann CM; Koeman JP; Sloet van Oldruitenborgh-Oosterbaan MM
    Tijdschr Diergeneeskd; 2006 Feb; 131(4):114-8. PubMed ID: 16514970
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Environmental zinc and cadmium pollution associated with generalized osteochondrosis, osteoporosis, and nephrocalcinosis in horses.
    Gunson DE; Kowalczyk DF; Shoop CR; Ramberg CF
    J Am Vet Med Assoc; 1982 Feb; 180(3):295-9. PubMed ID: 7056680
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A survey of adverse effects associated with ivermectin use in Louisiana horses.
    Karns PA; Luther DG
    J Am Vet Med Assoc; 1984 Oct; 185(7):782-3. PubMed ID: 6548469
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Safety evaluation of mebendazole in horses.
    Bennett DG; Bickford AA; Lund JE
    Am J Vet Res; 1974 Jul; 35(7):1003-4. PubMed ID: 4841930
    [No Abstract]   [Full Text] [Related]  

  • 48. Safety and toxicity of a gel formulation of dichlorvos in the foal.
    Albert JR; Stearns SM
    Am J Vet Res; 1973 Oct; 34(10):1359-61. PubMed ID: 4748248
    [No Abstract]   [Full Text] [Related]  

  • 49. Iron toxicity in neonatal foals.
    Mullaney TP; Brown CM
    Equine Vet J; 1988 Mar; 20(2):119-24. PubMed ID: 3371313
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Macrolide-induced hyperthermia in foals: Role of impaired sweat responses.
    Stieler AL; Sanchez LC; Mallicote MF; Martabano BB; Burrow JA; MacKay RJ
    Equine Vet J; 2016 Sep; 48(5):590-4. PubMed ID: 26174202
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Adverse drug event reports at the United States Food And Drug Administration Center for Veterinary Medicine.
    Hampshire VA; Doddy FM; Post LO; Koogler TL; Burgess TM; Batten PO; Hudson R; McAdams DR; Brown MA
    J Am Vet Med Assoc; 2004 Aug; 225(4):533-6. PubMed ID: 15344359
    [No Abstract]   [Full Text] [Related]  

  • 52. Toxic effects of lasalocid in horses.
    Hanson LJ; Eisenbeis HG; Givens SV
    Am J Vet Res; 1981 Mar; 42(3):456-61. PubMed ID: 7271010
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Off-label use of lincomycin hydrochloride in 2 horses. Dysbacteriosis and fatal complications due to inadequate symptomatic therapy].
    van Miert AS
    Tijdschr Diergeneeskd; 1995 Jun; 120(12):361-3. PubMed ID: 7597685
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Moxidectin toxicosis in a puppy successfully treated with intravenous lipids.
    Crandell DE; Weinberg GL
    J Vet Emerg Crit Care (San Antonio); 2009 Apr; 19(2):181-6. PubMed ID: 19691569
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharyngeal rupture in a horse.
    Hamilton DP
    J Am Vet Med Assoc; 1973 Mar; 162(6):466. PubMed ID: 4692303
    [No Abstract]   [Full Text] [Related]  

  • 56. Gallium maltolate: safety in neonatal foals following multiple enteral administrations.
    Martens RJ; Cohen ND; Fajt VR; Nerren JR; Chaffin MK; Taylor RJ; Bernstein LR
    J Vet Pharmacol Ther; 2010 Apr; 33(2):208-12. PubMed ID: 20444048
    [No Abstract]   [Full Text] [Related]  

  • 57. Use of dopamine hydrochloride during general anesthesia in the treatment of advanced atrioventricular heart block in four foals.
    Whitton DL; Trim CM
    J Am Vet Med Assoc; 1985 Dec; 187(12):1357-61. PubMed ID: 4086353
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ivermectin toxicosis in a neonatal foal.
    Godber LM; Derksen FJ; Williams JF; Mahmoud B
    Aust Vet J; 1995 May; 72(5):191-2. PubMed ID: 7661821
    [No Abstract]   [Full Text] [Related]  

  • 59. Pharmacologic considerations in drug therapy in foals.
    Caprile KA; Short CR
    Vet Clin North Am Equine Pract; 1987 Apr; 3(1):123-44. PubMed ID: 3555723
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Goiter in foals caused by excessive iodine.
    Driscoll J; Hintz HF; Schryver HF
    J Am Vet Med Assoc; 1978 Oct; 173(7):858-9. PubMed ID: 711608
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.